Skip to content
Unrated Drug recall · FDA · Published October 20, 2023

Glenmark Bisoprolol/Hydrochlorothiazide Tablets Recall: Failed Impurities Risk

Glenmark recalls 5mg/6.25mg bisoprolol and hydrochlorothiazide tablets due to failed impurities tests. RX-only 100-count bottles with specific NDC and lot numbers. No remedy stated in recall notice.

🇺🇸 FDA recall #D-0085-2024DrugGlenmark ›
Take action

Contact the company

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr · Mahwah, NJ 07430-2009
✎ GovInfoNow plain-language explainer

Glenmark is recalling 100-count bottles of bisoprolol and hydrochlorothiazide tablets (5mg/6.25mg) that were manufactured with failed impurities tests. This recall affects prescription-only medications that could pose a risk to users if the impurities cause harm. Read more at govinfonow.com/recall/33036-glenmark-bisoprolol-hydrochlorothiazide-tablets-recall-failed-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33036-glenmark-bisoprolol-hydrochlorothiazide-tablets-recall-failed-impurities-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0085-2024

Cite this page

“Glenmark Bisoprolol/Hydrochlorothiazide Tablets Recall: Failed Impurities Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33036-glenmark-bisoprolol-hydrochlorothiazide-tablets-recall-failed-impurities-risk. Based on FDA recall #D-0085-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0085-2024%22&limit=1).

The FDA announced on Oct. 20, 2023, that Glenmark Pharmaceuticals Inc., USA voluntarily recalled Bisoprolol Fumarate and Hydrochlorothiazide Tablets due to failed impurity specifications. The recall affects 480 bottles distributed nationwide.

How to tell if you have it

  • Brand: Glenmark
  • Product: Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 5mg/6.25mg
  • Packaging: 100-count Bottle, RX only
  • NDC: 68462-879-01
  • Lot#: 17212352
  • Expiration Date: 11/31/2023
  • Quantity: 480 bottles

The hazard

The tablets failed impurity and degradation specifications, according to the FDA. The agency classified this as a Class III recall.

Context

GovInfoNow's records show Glenmark Pharmaceuticals Inc., USA has had 54 other recalls on record since Nov. 20, 2017. Other recent recalls of similar products include Glenmark Azelaic Acid Gel 15% Recall (July 23, 2026), Glenmark Alyacen Birth Control Tablets Recall (May 27, 2026), and Glenmark Ondansetron Tablets Recall (Dec. 30, 2025). Other recent recalls of similar products include Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (Jan. 21, 2026), Sagent Busulfan Injection Recall (May 4, 2026), and Macleods Olanzapine Tablets 5mg Recall (Aug. 27, 2026).

How to tell if you have this one

Check for the 100-count bottle labeled 5mg/6.25mg bisoprolol and hydrochlorothiazide tablets. Look for NDC code 68462-879-01 and lot number 17212352 on the packaging.

  • Brand
    Glenmark
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC code 68462-879-01 and lot number 17212352 on the bottle to confirm it's the recalled item.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

1. Firm started the recall: Oct 20, 202312. FDA classified it Class III: Nov 2, 202323. Published in FDA’s Enforcement Report: Nov 8, 202334. FDA terminated the recall: Aug 16, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the expiration date for the recalled product?

The recalled product expires November 30, 2023, as indicated by the lot number 17212352.

Similar recalls

Other Glenmark recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0085-2024 (October 20, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0085-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA